Evolution and Clinical Importance of Extended-Spectrum β-Lactamases
- 1 February 2001
- Vol. 119 (2) , 391S-396S
- https://doi.org/10.1378/chest.119.2_suppl.391s
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Why are antibiotic resistance genes so resistant to elimination?Antimicrobial Agents and Chemotherapy, 1997
- Ampicillin susceptibilities of vaginal and placental isolates of group B streptococcus and Escherichia coli obtained between 1992 and 1994Antimicrobial Agents and Chemotherapy, 1997
- Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam AntibioticsClinical Infectious Diseases, 1997
- A Practical Look at the Clinical Usefulness of the Beta-Lactam/Beta-Lactamase Inhibitor CombinationsAnnals of Pharmacotherapy, 1996
- Antimicrobial Resistance Rates Among Aerobic Gram-Negative Bacilli Recovered from Patients in Intensive Care Units: Evaluation of a National Postmarketing Surveillance ProgramClinical Infectious Diseases, 1996
- A functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrobial Agents and Chemotherapy, 1995
- Resistance to Antibiotics Mediated by Target AlterationsScience, 1994
- Efficacy of Different β-Lactams against an Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Strain in the Rat Intra-Abdominal Abscess ModelAntimicrobial Agents and Chemotherapy, 1991
- Emergence of Resistance to Imipenem During Therapy for Pseudomonas aeruginosa InfectionsThe Journal of Infectious Diseases, 1986
- The structure of β-lactamasesPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980